Literature DB >> 4951870

Thyroid function in breast cancer.

J Myhill, T S Reeve, I B Hales.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 4951870     DOI： 10.1530/acta.0.0510290

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN： 0001-5598


× No keyword cloud information.
  8 in total

1.  The interpretation of the serum protein-bound iodine: A review.

Authors:  J D Acland
Journal:  J Clin Pathol       Date:  1971-04       Impact factor: 3.411

2.  High prevalence of breast cancer in patients with benign thyroid diseases.

Authors:  I Muller; A Pinchera; E Fiore; V Belardi; V Rosellini; E Giustarini; C Giani
Journal:  J Endocrinol Invest       Date:  2010-07-01       Impact factor: 4.256

3.  Thyroid status and breast cancer. Reappraisal of an old relationship.

Authors:  A R Moossa; D A Evans; A C Brewer
Journal:  Ann R Coll Surg Engl       Date:  1973-09       Impact factor: 1.891

4.  Antithyroid peroxidase antibody positivity is associated with lower incidence of metastasis in breast cancer.

Authors:  Yasemin Kemal; Guzin Demirag; Kubilay Ekiz; Idris Yucel
Journal:  Mol Clin Oncol       Date:  2015-03-02

5.  Breast cancer and thyroid diseases: analysis of 867 consecutive cases.

Authors:  C Chiappa; F Rovera; S Rausei; S Del Ferraro; A Fachinetti; M Lavazza; V Marchionini; V Arlant; M L Tanda; E Piantanida; H Y Kim; A Anuwong; G Dionigi
Journal:  J Endocrinol Invest       Date:  2016-09-13       Impact factor: 4.256

Review 6.  Thyroid disease in relation to breast cancer.

Authors:  H Vorherr
Journal:  Klin Wochenschr       Date:  1978-12-01

7.  Breast cancer concurrent with hyperthyroidism: a case report.

Authors:  A Tsuchiya; I Kimijima; S Suzuki; I Higuchi; I Watanabe; S Endo
Journal:  Jpn J Surg       Date:  1981-03

8.  Breast cancer in association with thyroid disorders.

Authors:  Orhan Turken; Yavuz NarIn; Sezai DemIrbas; M Emin Onde; Ozkan Sayan; E Gokhan KandemIr; Mustafa YaylacI; Ahmet Ozturk
Journal:  Breast Cancer Res       Date:  2003-06-05       Impact factor: 6.466
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.